GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Immunovia AB (publ) IMMNOV.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.03

-10.43%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 685,000

FY2016FY2025

Net income

−SEK 145.9m

FY2016FY2025

Free cash flow

−SEK 84.0m

FY2016FY2025

Shareholders' equity

SEK 64.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 685,000SEK 931,000SEK 1.6mSEK 1.1mSEK 844,000SEK 362,000SEK 356,000SEK 332,595SEK 148,963SEK 177,284
Research and development—SEK 28.4mSEK 34.4mSEK 47.9mSEK 43.0mSEK 48.1mSEK 34.2mSEK 26.0mSEK 24.0mSEK 24,293
Operating income−SEK 79.5m−SEK 109.4m−SEK 281.9m−SEK 191.2m−SEK 166.7m−SEK 144.6m−SEK 113.2m−SEK 87.7m−SEK 45.5m−SEK 15.0m
Net income−SEK 145.9m−SEK 76.5m−SEK 309.4m−SEK 145.0m−SEK 157.4m−SEK 147.5m−SEK 114.5m−SEK 86.5m−SEK 45.2m−SEK 14.7m
Diluted earnings per share-0.28-0.45-6.83-5.95-6.95-6.52-5.83-4.43-2.61-0.88

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 88.2mSEK 33.0mSEK 98.7mSEK 300.6mSEK 493.8mSEK 661.2mSEK 419.4mSEK 477.4mSEK 250.8mSEK 283.4m
Cash and short-term investmentsSEK 77.5mSEK 25.3mSEK 76.8mSEK 106.0mSEK 287.4mSEK 468.5mSEK 263.3mSEK 386.1mSEK 192.4mSEK 259.1m
Total liabilitiesSEK 23.5mSEK 21.4mSEK 31.7mSEK 56.8mSEK 59.9mSEK 61.8mSEK 61.8mSEK 15.4mSEK 14.0mSEK 6.8m
DebtSEK 857,000SEK 680,000SEK 4.3mSEK 37.6mSEK 33.3mSEK 33.1mSEK 37.7m———
Shareholders' equitySEK 64.7mSEK 11.6mSEK 67.0mSEK 243.8mSEK 433.9mSEK 599.4mSEK 357.6mSEK 462.0mSEK 236.8mSEK 276.6m
Shares outstanding529m170m45m24m23m23m20m20m17m17m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 78.4m−SEK 96.8m−SEK 147.1m−SEK 175.6m−SEK 152.6m−SEK 120.7m−SEK 92.0m−SEK 84.1m−SEK 46.3m−SEK 11.9m
Capital spending−SEK 5.6m—−SEK 1.1m−SEK 1.6m−SEK 24.2m−SEK 47.5m−SEK 36.6m−SEK 37.3m−SEK 31.3m−SEK 30.8m
Free cash flow−SEK 84.0m−SEK 96.8m−SEK 148.1m−SEK 177.2m−SEK 176.8m−SEK 168.2m−SEK 128.6m−SEK 121.4m−SEK 77.6m−SEK 42.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 381,000SEK 374,000SEK 354,000SEK 101,000SEK 90,000SEK 139,000SEK 455,000SEK 235,000
Operating income−SEK 22.9m−SEK 18.4m−SEK 16.4m−SEK 25.0m−SEK 20.0m−SEK 18.9m−SEK 30.1m−SEK 31.2m
Net income−SEK 22.8m−SEK 18.4m−SEK 17.3m−SEK 29.7m−SEK 41.1m−SEK 57.8mSEK 3.1m−SEK 51.1m
Diluted earnings per share-0.03-0.03-0.03-0.06-0.08-0.110.02-0.30
Cash from operations−SEK 20.0m−SEK 20.0m−SEK 19.0m−SEK 16.0m−SEK 18.0m−SEK 24.0m−SEK 28.0m−SEK 17.0m
Capital spending——−SEK 5.0m−SEK 5.0m————
Free cash flow——−SEK 24.0m−SEK 21.0m————
Total assetsSEK 48.0mSEK 65.7mSEK 88.2mSEK 37.7mSEK 34.8mSEK 43.8mSEK 33.0mSEK 63.1m
Cash and short-term investmentsSEK 34.9mSEK 56.1mSEK 77.5mSEK 26.6mSEK 29.3mSEK 37.7mSEK 25.3mSEK 54.2m
DebtSEK 3.3mSEK 479,000SEK 857,000SEK 20.4mSEK 467,000SEK 110,000SEK 680,000SEK 1.5m
Shareholders' equitySEK 23.6mSEK 46.5mSEK 64.7m−SEK 8.3mSEK 17.7mSEK 29.3mSEK 11.6mSEK 38.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-15.7%13.6%12.8%
Operating income-25.4%-11.3%26.8%
Net income0.2%-0.2%34.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-11690.3%-15267.2%-17563.0%-18369.8%
Net margin-13765.8%-15611.8%-17715.2%-18488.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-0.5-0.6-0.1-0.5-1.2-2.0-3.5-3.5-3.8-11.8
Price to sales108.848.012.262.8225.5—————

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 3 Feb 2026

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.